Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

di Calverley, Peter, Rogliani, Paola, Papi, Alberto
Pubblicato in Drug Saf (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?

di Papi, Alberto, Beghé, Bianca, Fabbri, Leonardo M.
Pubblicato in Am J Respir Crit Care Med (2021)

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

di Saturni, Sara, Contoli, Marco, Spanevello, Antonio, Papi, Alberto
Pubblicato in Allergy Asthma Immunol Res (2015)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

di Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Pubblicato in Int J Chron Obstruct Pulmon Dis (2017)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study

di Papi, Alberto, Di Stefano, Andrea F. D., Radicioni, Milko
Pubblicato in Adv Ther (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

di Scichilone, Nicola, Benfante, Alida, Morandi, Luca, Bellini, Federico, Papi, Alberto
Pubblicato in Patient Relat Outcome Meas (2014)

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

di Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Pubblicato in NPJ Prim Care Respir Med (2016)

Mechanisms of rhinovirus-induced asthma

di Papadopoulos, Nikolaos G, Papi, Alberto, Psarras, Stelios, Johnston, Sebastian L
Pubblicato in Paediatr Respir Rev (2004)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

di Nicolini, Gabriele, Scichilone, Nicola, Bizzi, Andrea, Papi, Alberto, Fabbri, Leonardo M
Pubblicazione 2008

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

di Vanfleteren, Lowie, Fabbri, Leonardo M, Papi, Alberto, Petruzzelli, Stefano, Celli, Bartolome
Pubblicato in Int J Chron Obstruct Pulmon Dis (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

di Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Pubblicato in Int J Chron Obstruct Pulmon Dis (2019)

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

di Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Pubblicato in Respir Res (2019)

Models of infection and exacerbations in COPD

di Papi, Alberto, Contoli, Marco, Gaetano, Caramori, Mallia, Patrick, Johnston, Sebastian L
Pubblicato in Curr Opin Pharmacol (2007)

Management of chronic refractory cough in adults

di Visca, Dina, Beghè, Bianca, Fabbri, Leonardo Michele, Papi, Alberto, Spanevello, Antonio
Pubblicato in Eur J Intern Med (2020)

New drugs targeting Th2 lymphocytes in asthma

di Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto
Pubblicazione 2008

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with...

di Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Pubblicato in BMC Pulm Med (2016)

Treatment strategies for asthma: reshaping the concept of asthma management

di Papi, Alberto, Blasi, Francesco, Canonica, Giorgio Walter, Morandi, Luca, Richeldi, Luca, Rossi, Andrea
Pubblicato in Allergy Asthma Clin Immunol (2020)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

di Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Pubblicato in Asthma Res Pract (2021)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

di Papi, Alberto, Nicolini, Gabriele, Crimi, Nunzio, Fabbri, Leonardo, Olivieri, Dario, Rossi, Andrea, Paggiaro, Pierluigi
Pubblicazione 2012

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

di Papi, Alberto, Jones, Paul W, Dalvi, Prashant S, McAulay, Kirsten, McIver, Tammy, Dissanayake, Sanjeeva
Pubblicato in Int J Chron Obstruct Pulmon Dis (2015)